204 related articles for article (PubMed ID: 32283222)
1. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent.
Tripathi SK; Biswal BK
Pharmacol Res; 2020 Jun; 156():104772. PubMed ID: 32283222
[TBL] [Abstract][Full Text] [Related]
2. Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.
Piska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Pękala E
Eur J Med Chem; 2018 Aug; 156():13-20. PubMed ID: 30006159
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Tripathi SK; Panda M; Biswal BK
Food Chem Toxicol; 2019 Mar; 125():566-582. PubMed ID: 30685472
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S; Agnihotri N
Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine as anticancer agent: The story so far about killing many birds with one stone.
Farooqi AA; Attar R; Yaylim I; Qureshi MZ; Todorovska M; Karatoprak GŞ; Najafi S; Sabitaliyevich UY; Zhenisovna TG; De Sousa DP; Lin X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):102-107. PubMed ID: 30213297
[TBL] [Abstract][Full Text] [Related]
6. Overview of the therapeutic potential of piplartine (piperlongumine).
Bezerra DP; Pessoa C; de Moraes MO; Saker-Neto N; Silveira ER; Costa-Lotufo LV
Eur J Pharm Sci; 2013 Feb; 48(3):453-63. PubMed ID: 23238172
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine induces apoptosis and G
Zhou J; Huang Z; Ni X; Lv C
Toxicol In Vitro; 2020 Jun; 65():104775. PubMed ID: 31987842
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity.
Niu M; Xu X; Shen Y; Yao Y; Qiao J; Zhu F; Zeng L; Liu X; Xu K
Chem Biol Interact; 2015 Jul; 237():66-72. PubMed ID: 26026911
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems.
Luan F; He X; Zeng N
J Pharm Pharmacol; 2020 Nov; 72(11):1491-1512. PubMed ID: 32696989
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption.
Song X; Gao T; Lei Q; Zhang L; Yao Y; Xiong J
Nutr Cancer; 2018 Apr; 70(3):502-511. PubMed ID: 29543494
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X
Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726
[TBL] [Abstract][Full Text] [Related]
13. Piperine as a Potential Anti-cancer Agent: A Review on Preclinical Studies.
Manayi A; Nabavi SM; Setzer WN; Jafari S
Curr Med Chem; 2018; 25(37):4918-4928. PubMed ID: 28545378
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells.
Rawat L; Nayak V
Chem Biol Interact; 2022 Feb; 354():109832. PubMed ID: 35085581
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
[TBL] [Abstract][Full Text] [Related]
16. Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
Liu D; Qiu XY; Wu X; Hu DX; Li CY; Yu SB; Pan F; Chen XQ
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):165-172. PubMed ID: 29037814
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C
Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568
[TBL] [Abstract][Full Text] [Related]
18. Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine.
Prasad S; Tyagi AK
Curr Pharm Des; 2016; 22(27):4151-9. PubMed ID: 27262330
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer.
Mitra S; Biswas P; Bandyopadhyay A; Gadekar VS; Gopalakrishnan AV; Kumar M; Radha ; Nandy S
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2637-2650. PubMed ID: 37955690
[TBL] [Abstract][Full Text] [Related]
20. Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: A mechanistic investigation.
Yan WJ; Wang Q; Yuan CH; Wang F; Ji Y; Dai F; Jin XL; Zhou B
Free Radic Biol Med; 2016 Aug; 97():109-123. PubMed ID: 27233942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
